tugas kasus farklin bu yulia.docx

7/24/2019 Tugas Kasus Farklin Bu Yulia.docx

1/8

1. Novomix

Manufacturer Novo NordiskContents Insulin aspart 30%, protamine crystallised insulin aspart 70%

Indications Treatment of DM.

Click to vie NovoMi! 30 "le!#en detailed prescri$in information

Dosae SCIndividuali&ed dosae. 'sual dose( 0.)*+ ukday.


-verdosae ie NovoMi! 30 "le!#en overdosaefor action to $e taken in t/e event of an overdose.

dministration 1/ould $e taken it/ food( dminister immediately $efore or soon after a meal.

Contraindications 2ypersensitivity. 2ypolycemia.


1pecial #recautions Do not administer I. Inadeuate dosin 4 discontinuation of treatment may lead to /yperlycaeketoacidosis. -mission of meals or unplanned strenuous e!ercises may lead to /ypolycaemia

disease or medication may delay food a$sorption 4or increase insulin reuirement. 6enal 4 /e

impairment. Transferrin from ot/er insulin products, Not to $e used in insulin infusion pumps.

Com$ination t/ia&olidinediones s/ould $e discontinued if any deterioration in cardiac sympto

occurs. May impair a$ility to drive or operate mac/inery as a result of /ypolycaemia. #renanc

lactation. C/ildn 4 adolescents +8 yr.


dverse Dru 6eactions 2ypolycemia. 'rticaria, ras/, eruptions, anap/ylactic reactions. #erip/eral neuropat/y. 6efrac

disorder, dia$etic retinopat/y. 9ipodystrop/y. In: site reaction, oedema.

ieD6 Monitorin "orm

Dru Interactions 6educe insulin reuirements oral /ypolycemics, octreotide, M-Is, nonselective ;*adrener

$lockers, C< in/i$itors, salicylates, alco/ol, ana$olic steroids 4 sulfonamides5 increase insulin

reuirements -Cs, t/ia&ides, lucocorticoids, t/yroid /ormones, sympat/omimetics 4 dana&

$lockin aents may mask t/e symptoms of /ypolycaemia. lco/ol may intensify 4 prolon t/

lucose loerin effect of insulin.

#renancy Cateory ='1

"D>

Category B( t/at as not confirmed in controlled studies in omen in t/e

+sttrimester =and t/ere is no evidence of a risk in later trimesters>.

Caution "or 'sae "or caution aainst possi$le variation of p/ysical aspect of medicine... click to vie NovoMi! 30

"le!#en detailed prescri$in information

1torae ie NovoMi! 30 "le!#en storaeconditions for details to ensure optimal s/elf*life.

Description ie NovoMi! 30 "le!#en descriptionfor details of t/e c/emical structure and e!cipients =inact

components>.

Mec/anism of ction ie NovoMi! 30 "le!#en mec/anism of actionfor p/armacodynamics and p/armacokinetics d

MIM1 Class Insulin #reparations

TC Classification +0D0) * insulin aspart 5 ?elons to t/e class of intermediate*actin com$ined it/ fast*actin
http://www.idrtrade.com/Indonesia/Company/Info/Novo%20Nordiskhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#AdverseReactionshttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Interactionshttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Insulin%20Preparationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#AdverseReactionshttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Interactionshttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Insulin%20Preparationshttp://www.idrtrade.com/Indonesia/Company/Info/Novo%20Nordisk


2/8

insulins and analoues. 'sed in t/e treatment of dia$etes.

Dru Classification @

2. Omeprazol

Manufacturer Novo Nordisk

Contents Insulin aspart 30%, protamine crystallised insulin aspart 70%

Indications Treatment of DM.


Dosae SCIndividuali&ed dosae. 'sual dose( 0.)*+ ukday.


-verdosae ie NovoMi! 30 "le!#en overdosaefor action to $e taken in t/e event of an overdose.

dministration 1/ould $e taken it/ food( dminister immediately $efore or soon after a meal.

Contraindications 2ypersensitivity. 2ypolycemia.


1pecial #recautions Do not administer I. Inadeuate dosin 4 discontinuation of treatment may lead to /yperlycae

ketoacidosis. -mission of meals or unplanned strenuous e!ercises may lead to /ypolycaemia

disease or medication may delay food a$sorption 4or increase insulin reuirement. 6enal 4 /e

impairment. Transferrin from ot/er insulin products, Not to $e used in insulin infusion pumps.

Com$ination t/ia&olidinediones s/ould $e discontinued if any deterioration in cardiac sympto

occurs. May impair a$ility to drive or operate mac/inery as a result of /ypolycaemia. #renanc

lactation. C/ildn 4 adolescents +8 yr.


dverse Dru 6eactions 2ypolycemia. 'rticaria, ras/, eruptions, anap/ylactic reactions. #erip/eral neuropat/y. 6efrac

disorder, dia$etic retinopat/y. 9ipodystrop/y. In: site reaction, oedema.ieD6 Monitorin "orm

Dru Interactions 6educe insulin reuirements oral /ypolycemics, octreotide, M-Is, nonselective ;*adrener

$lockers, C< in/i$itors, salicylates, alco/ol, ana$olic steroids 4 sulfonamides5 increase insulin

reuirements -Cs, t/ia&ides, lucocorticoids, t/yroid /ormones, sympat/omimetics 4 dana&

$lockin aents may mask t/e symptoms of /ypolycaemia. lco/ol may intensify 4 prolon t/

lucose loerin effect of insulin.


"D>

Category B( t/at as not confirmed in controlled studies in omen in t/e

+sttrimester =and t/ere is no evidence of a risk in later trimesters>.

Caution "or 'sae "or caution aainst possi$le variation of p/ysical aspect of medicine... click to vie NovoMi! 30

"le!#en detailed prescri$in information

1torae ie NovoMi! 30 "le!#en storaeconditions for details to ensure optimal s/elf*life.

Description ie NovoMi! 30 "le!#en descriptionfor details of t/e c/emical structure and e!cipients =inact

components>.
http://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Novo%20Nordiskhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#AdverseReactionshttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Interactionshttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Novo%20Nordiskhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Indicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Dosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Overdosagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Contraindicationshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#SpecialPrecautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#AdverseReactionshttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Interactionshttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Cautionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Description


3/8

Mec/anism of ction ie NovoMi! 30 "le!#en mec/anism of actionfor p/armacodynamics and p/armacokinetics d

MIM1 Class Insulin #reparations

TC Classification +0D0) * insulin aspart 5 ?elons to t/e class of intermediate*actin com$ined it/ fast*actin

insulins and analoues. 'sed in t/e treatment of dia$etes.


3. Furosemid

Manufacturer "a/ren/eit

Contents "urosemide

Indications 9isted in Dosae.

Dosae TabEdema associated w/ CHF, hepatic cirrhosis, renal diseaseAdultA0*80 m as a sinle dose,

increased $y A0*B0 m *8 /rly until desired response is o$tained.Childn

A mk $ody t as a sinldose, increased $y +*A mk $ody t *8 /rly, until desired response is o$tained. In c/ildn nep/ro

syndrome dose may $e increased to ma! mk $ody t. Mild to moderate HTN, alone or in

combination w/ other antihypertensives & as ad!nctive treatment in hypertensive crisisInitially

m tice daily. InjInitially A0*B0 m IIM. Increase at A /rly intervals $y A0 m. If necessary in:ect a

furt/er A0*B0 m after A0 min. "c!te p!lmonary edemaInitially B0 m I. n additional A0*B0 m ma

administered after A0 min.

dministration May $e taken it/ or it/out food( May $e taken meals to reduce @I discomfort.

Contraindications 6enal function impairment5 oliuria, anuria5 /ypokalemia, /yponatremia5 /ypotension.

1pecial #recautions DM5 /istory of out5 /epatic function impairment5 /yperuricemia5 /istory of 19

Category C( and t/ere are no controlled studies in omen or studies in omen and animals

not availa$le. Drus s/ould $e iven only if t/e potential $enefit :ustifies t/e potential risk to t/e foetus

MIM1 Class Diuretics

TC Classification C03C0+ * furosemide 5 ?elons to t/e class of /i/*ceilin sulfonamide diuretics.


4. Nephrosteril

Manufacturer "resenius a$i
http://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Insulin%20Preparationshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Fahrenheithttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Diureticshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Fresenius%20Kabihttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/NovoMix%2030%20FlexPen/?type=full#Actionshttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Insulin%20Preparationshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Fahrenheithttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Diureticshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Fresenius%20Kabi


4/8

Contents #er $9*isoleucine ).+ , 9*leucine +0.3 , 9*lysine monoacetate +0.0+ =euiv to 9*lysine 7.+

met/ionine A.8 , acetylcysteine 0.) =euiv to 9*cysteine 0.37 >, 9*p/enylalanine 3.8 , 9*t/re

B.8 , 9*tryptop/an +.E , 9*valine .A , arinine B.E , 9*/istidine B.3 , aminoacetic acid 3.A

alanine .3 , 9*proline B.3 , 9*serine B.) , 9*malic acid +.) , lacial acetic acid +.38 . Total

acids 70 , total nitroen content +0.8 . or B00 m9day infused via central vein. "c!te renal %ail!re00 m9day infused via

vein.

Contraindications Impaired amino acid meta$olism, advanced /epatic impairment, severe cardiac insufficiency,

/yper/ydration, /ypokalemia, /yponatremia. 2epatic coma, in/erited a$normal amino acid

meta$olism, severe renal impairment or a&otemia, /yperammonemia.

1pecial #recautions 1upply sufficient . 6eularly monitor ater*electrolyte meta$olism, acid*$ase $alance 4 serum

2yperammonemia or consciousness disorders =discontinue>. Inadeuate administration of calo

dysfunction, /epatic disorders, @I $leedin, severe electrolyte im$alance, a$normal acid*$ase

$alance, severe acidosis. Faundice =c/ildn>. #renancy 4 lactation. . . C/est disco

palpitations5 increased 1@-T, 1@#T, total $iliru$in, ammonia, ?'N 4 creatinine5 acidosis5 fever

/eadac/e, vascular pain, loer e!tremity edema, /yperkalemia, dry mout/.

ieD6 Monitorin "orm

MIM1 Class #arenteral Nutritional #roducts

TC Classification ?0)?0+ * amino acids 5 ?elons to t/e class of solutions for parenteral nutrition used in I.. so


5. Kalitake

Manufacturer Dipa #/armala$ Intersains

Contents Ca polystyrene sulfonate

Indications 2yperkalemia due to acute 4 c/ronic renal failure.

Dosae Adult+)*30 daily orally, suspended in 30*)0 m9 ater, in 3*B divided doses. ChildnG adult d

dministration 1/ould $e taken on an empty stomac/.

Contraindications Intestinal o$struction.

1pecial #recautions Monitor 4 Ca levels at reular intervals durin t/erapy5 intestinal stenosis, @I ulcers,

/ypert/yroidism, multiple myeloma.

dverse Dru 6eactions Intestinal perforation 4 o$struction, constipation, nausea, anore!ia, stomac/ discomfort5 /ypoka

ieD6 Monitorin "orm

Dru Interactions ntacid 4 la!ative containin l, M or Ca, diitalis.


"D>
http://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Parenteral%20Nutritional%20Productshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Dipa%20Pharmalab%20Intersainshttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Parenteral%20Nutritional%20Productshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Dipa%20Pharmalab%20Intersainshttp://www.idrtrade.com/resources/portal/Indonesia/document/ADR_Form.pdfhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htm


5/8

Category C( and t/ere are no controlled studies in omen or studies in omen and anare not availa$le. Drus s/ould $e iven only if t/e potential $enefit :ustifies t/e potential risk to

foetus.

MIM1 Class ntidotes 4 Deto!ifyin ents

TC Classification 03


6/8

#rod!ct Code'( ?

(omposisi( itamin ?+ +.) m, vitamin ?A +.8 m, pantot/enic acid +0 m, niacinamide A0 m,vitamin ? +0 m, vitamin ?+A mc, vitamin C 0 m, folic acid + m, vitamin < +)m, $iotin 300 mc, "e +00 m

)ndi*asi( #ra dan pasca /emodialis

+osis( + ta$let per /ari

#emberian bat( Dapat di$erikan $ersama makanan aar dia$sorpsi le$i/ $aik atau :ika tim$ul rasatidak nyaman pada @I

(emasan( Ta$let salut selaput +00s

#. Klonidin

Manufacturer ?oe/riner Inel/eim

Contents Clonidine 2Cl

Indications 2TN. In:( 2ypertensive crisis.

Click to vie Catapres detailed prescri$in information

Dosae TabInitially 0.07)*0.+) m daily. May $e increased after A*B k. 1evere cases( 0.3 m up to 3 t

daily. Inj0.A mckmin I infusion at a rate not to e!ceed 0.) mckmin. Ma!( 0.+) minfusi

reuired, + amp up to B times daily.


-verdosae ie Catapres overdosaefor action to $e taken in t/e event of an overdose.

dministration May $e taken it/ or it/out food.

Contraindications 1ick sinus syndrome. And or 3rd deree $lock.


1pecial #recautions Diseases affectin r/yt/mic 4 conduction system of t/e /eart5 renal failure, disorders of cere

perip/eral perfusion, depression, polyneuropat/y, constipation. May impair a$ility to drive or op

mac/inery. 6educe dose radually over A*B days /en discontinuin treatment.


dverse Dru 6eactions Initially dry mout/, sedation 4 fatiue5 ort/ostatic complaints.

ieD6 Monitorin "orm

1ide


7/8


"D>

Category C( and t/ere are no controlled studies in omen or studies in omen and an

are not availa$le. Drus s/ould $e iven only if t/e potential $enefit :ustifies t/e potential risk to

foetus.

1torae ie Catapres storaeconditions for details to ensure optimal s/elf*life.

Description ie Catapres descriptionfor details of t/e c/emical structure and e!cipients =inactive compon

Mec/anism of ction ie Catapres mec/anism of actionfor p/armacodynamics and p/armacokinetics details.

MIM1 Class -t/er nti/ypertensives

TC Classification C0AC0+ * clonidine 5 ?elons to t/e class of imida&oline receptor aonists, centrally*actin

antiadreneric aents. 'sed in t/e treatment of /ypertension.


$. %mdixal

Manufacturer 1ando&

Contents mlodipine maleate

Indications rterial 2TN. #rop/ylactic treatment of anina pectoris.

Dosae AdultInitially ) m once daily. Ma!( +0 m.

dministration May $e taken it/ or it/out food.

Contraindications 2ypersensitivity to ot/er di/ydropyridines5 cardioenic s/ock, severe aortic stenosis, unsta$le a

pectoris, acute MI, severe /ypotension, severe /epatic dysfunction.

1pecial #recautions 2epatic failure, renal insufficiency dependent on dialysis5 /ypotension =systolic ?# E0 mm2>

#renancy 4 lactation. May impair a$ility to drive or operate mac/inery.

dverse Dru 6eactions Nausea, a$dominal pain, e!ant/ema, /eadac/e, fatiue, drosiness, somnolence, edema,

palpitations, di&&iness, flus/in.
http://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Actionshttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Other%20Antihypertensiveshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Sandozhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/viewer/html/PregDef.htmhttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Storagehttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Descriptionhttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Actionshttp://www.idrtrade.com/Indonesia/drug/info/Catapres/?type=full#Actionshttp://www.idrtrade.com/Indonesia/Browse/Classification/http://www.idrtrade.com/Indonesia/drug/search?q=Other%20Antihypertensiveshttp://www.idrtrade.com/Indonesia/viewer/html/PoisonCls.htmhttp://www.idrtrade.com/Indonesia/Company/Info/Sandoz


8/8

ieD6 Monitorin "orm

Dru Interactions

tugas kasus farklin bu yulia.docx

Documents